Summary of current data for antiplatelet therapy in stroke prevention.
▪ Aspirin better than placebo
▪ No evidence of greater effectiveness of high-dose aspirin compared to low-dose aspirin
▪ Aspirin plus extended-release dipyridamole (ER-DP) more effective than aspirin alone
▪ Clopidogrel more effective than aspirin alone
▪ Aspirin plus clopidogrel no more effective than clopidogrel alone, but with substantially more bleeding
▪ Aspirin plus ER-DP and clopidogrel equivalent, but slightly more bleeding with aspirin plus ER-DP
Sign In or Create an Account